BrainStorm Cell Therapeutics Inc. (BCLI) stock
BCLIOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.77−0.01 (-1.17%)
Close on Oct 19, 2026Market cap $8.50MP/E –Yield –
BrainStorm Cell Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
BrainStorm Cell Therapeutics's market cap was $8.50M on Oct 19, 2026, against $6.58M a year earlier. Over the last 5 years it ranged from $5.62M to $161.27M, with a median of $18.32M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $8.50M | +39.2% |
| 2025 | Dec 31, 2025 | $6.10M | -49.4% |
| 2024 | Dec 31, 2024 | $12.05M | -1.5% |
| 2023 | Dec 29, 2023 | $12.24M | -79.6% |
| 2022 | Dec 30, 2022 | $59.93M | -58.7% |
| 2021 | Dec 31, 2021 | $145.11M | +1.5% |
| 2020 | Dec 31, 2020 | $143.00M | +47.8% |
| 2019 | Dec 31, 2019 | $96.76M | +31.7% |
| 2018 | Dec 31, 2018 | $73.49M | -0.5% |
| 2017 | Dec 29, 2017 | $73.86M | +55.6% |
| 2016 | Dec 30, 2016 | $47.47M | -10.2% |
| 2015 | Dec 31, 2015 | $52.86M | -27.1% |
| 2014 | Dec 31, 2014 | $72.49M | +128.5% |
| 2013 | Dec 31, 2013 | $31.72M | -3.9% |
| 2012 | Dec 31, 2012 | $33.02M | +25.2% |
| 2011 | Dec 30, 2011 | $26.38M | – |
See a number that looks wrong?